Medicalgorithmics (FRA:B8E) Moat Score: 0/10 (As of Jul. 02, 2026)


FRA:B8E Medicalgorithmics SA FRA:B8E
72 GF Score
Price €5.94
GF Value €6.00
! 4 Warning Signs
View Full Analysis

What is Medicalgorithmics Moat Score?

Medicalgorithmics has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Medicalgorithmics has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Medicalgorithmics might have No Moat - No discernible moat.

Medicalgorithmics  (FRA:B8E) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Medicalgorithmics Moat Score Related Terms

FRA:B8E
72GF Score
Medicalgorithmics SA FRA:B8E
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Medicalgorithmics (FRA:B8E) Overvalued in 2026?

Based on GuruFocus' analysis, Medicalgorithmics stock appears to be undervalued. The current stock price of €5.94 is trading 1% below its estimated GF Value™ of €6.00.

Key valuation signals for FRA:B8E:

  • Moat Score: 0
  • GF Value™: €6.00 vs. price of €5.94 (1% below fair value)
  • GF Score™: 72/100 with 4 warning signs

No single metric tells the full story. See the FRA:B8E stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medicalgorithmics Business Description

Other Exchanges MDG:Poland
Address Al Jerozolimskie 81, 19 Floor, Central Tower Building, Warsaw, POL, 02-001
Medicalgorithmics SA is a medical technology company. It is engaged in the development of Digital Signal Processing (DSP) algorithms development and software and hardware electronics design for medical applications. The company specializes in providing advance technological solutions in the field of cardiac diagnostics, with a particular focus on ECG signal analysis. The group concentrates on the production and development of its flagship product Pocket ECG - a system for remote monitoring of cardiac arrhythmias. The offered solutions include algorithms and diagnostic systems used in remote heart monitoring. The company operates in Poland, the USA, and other, with majority of revenue from the USA.
72GF Score

Get the complete analysis for FRA:B8E

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.94
Price
€6.00
GF Value